FDA Approves Darzalex (daratumumab) Split-Dosing Regimen

Article Link: FDA Approves Darzalex (daratumumab) Split-Dosing Regimen

Horsham, PA, February 12, 2019 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved a split-dosing regimen for Darzalex® (daratumumab), providing…

Source: FDA New Drug Approvals